- Home
- RCKT vs GRDN Comparison
RCKT vs GRDN Comparison
Compare RCKT & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- GRDN
- Stock Information
- Founded
- RCKT 1999
- GRDN 2004
- Country
- RCKT United States
- GRDN United States
- Employees
- RCKT N/A
- GRDN N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- GRDN Retail-Drug Stores and Proprietary Stores
- Sector
- RCKT Health Care
- GRDN Consumer Staples
- Exchange
- RCKT Nasdaq
- GRDN Nasdaq
- Market Cap
- RCKT 1.3B
- GRDN 1.4B
- IPO Year
- RCKT N/A
- GRDN 2024
- Fundamental
- Price
- RCKT $11.74
- GRDN $22.13
- Analyst Decision
- RCKT Strong Buy
- GRDN Strong Buy
- Analyst Count
- RCKT 11
- GRDN 2
- Target Price
- RCKT $50.27
- GRDN $22.50
- AVG Volume (30 Days)
- RCKT 1.3M
- GRDN 166.6K
- Earning Date
- RCKT 11-07-2024
- GRDN 02-15-2025
- Dividend Yield
- RCKT N/A
- GRDN N/A
- EPS Growth
- RCKT N/A
- GRDN N/A
- EPS
- RCKT N/A
- GRDN N/A
- Revenue
- RCKT N/A
- GRDN $1,170,907,000.00
- Revenue This Year
- RCKT N/A
- GRDN $18.05
- Revenue Next Year
- RCKT $234,928.88
- GRDN $9.55
- P/E Ratio
- RCKT N/A
- GRDN N/A
- Revenue Growth
- RCKT N/A
- GRDN 16.86
- 52 Week Low
- RCKT $11.58
- GRDN $14.16
- 52 Week High
- RCKT $32.53
- GRDN $25.74
- Technical
- Relative Strength Index (RSI)
- RCKT 27.69
- GRDN N/A
- Support Level
- RCKT $11.58
- GRDN N/A
- Resistance Level
- RCKT $15.00
- GRDN N/A
- Average True Range (ATR)
- RCKT 0.82
- GRDN 0.00
- MACD
- RCKT -0.09
- GRDN 0.00
- Stochastic Oscillator
- RCKT 4.65
- GRDN 0.00
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs, and .BHFs.